Which means it is possible, in principle, to design molecules that produce the parts of the GLP-1 effect that you want (appetite suppression, glycemic control, cardiovascular benefit) while minimizing the parts that you do not (gastrointestinal misery, certain forms of receptor downregulation, possibly some of the off-target effects we are still characterizing)
Stimulating telomerase activity , the enzyme responsible for maintaining and elongating telomeres
One big caveat: The data points below are sourced from a mix of surveys, retrospective studies, randomized control trials, and industry research reports the links between them are not causal (far from it)
Because alternative dosing schedules haven't been studied as rigorously as FDA-approved regimens, doctors still don't know whether they'll deliver the same results or carry the same risks
Meanwhile, studies suggest NAD+ supports cellular health and overall energy levels
At three months from baseline, the mean change in HbA1c was significant at -9.68 mmol/mol